These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31918216)

  • 1. Treating cancer with immunotherapy in HIV-positive patients: A challenging reality.
    Guaitoli G; Baldessari C; Maur M; Mussini C; Meschiari M; Barbieri F; Cascinu S; Bertolini F
    Crit Rev Oncol Hematol; 2020 Jan; 145():102836. PubMed ID: 31918216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.
    Frega S; Ferro A; Bonanno L; Guarneri V; Conte P; Pasello G
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111093
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer.
    Ostios-Garcia L; Faig J; Leonardi GC; Adeni AE; Subegdjo SJ; Lydon CA; Rangachari D; Huberman MS; Sehgal K; Shea M; VanderLaan PA; Cheng MP; Marty FM; Hammond SP; Costa DB; Awad MM
    J Thorac Oncol; 2018 Jul; 13(7):1037-1042. PubMed ID: 29631035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV and cancer: Update 2020].
    Abbar B; Veyri M; Solas C; Poizot-Martin I; Spano JP
    Bull Cancer; 2020 Jan; 107(1):21-29. PubMed ID: 31980144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors.
    Yekedüz E; Utkan G; Ürün Y
    Future Oncol; 2022 Feb; 18(4):413-416. PubMed ID: 35018793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in People With HIV and Cancer.
    Puronen CE; Ford ES; Uldrick TS
    Front Immunol; 2019; 10():2060. PubMed ID: 31555284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Cancer in Persons Living with HIV Infection.
    Goedert JJ; Hosgood HD; Biggar RJ; Strickler HD; Rabkin CS
    Trends Cancer; 2016 Aug; 2(8):416-428. PubMed ID: 27891533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung cancer in HIV-infected patients].
    Domblides C; Canellas A; Wislez M; Fallet V; Antoine M; Crequit P; Cadranel J; Lavolé A
    Bull Cancer; 2018 Jan; 105(1):111-119. PubMed ID: 29269175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questions.
    Remon J; Vilariño N; Reguart N
    Cancer Treat Rev; 2018 Mar; 64():21-29. PubMed ID: 29454155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?
    Ferrara R; Mezquita L; Auclin E; Chaput N; Besse B
    Cancer Treat Rev; 2017 Nov; 60():60-68. PubMed ID: 28889085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer.
    Yang J; Chen J; Wei J; Liu X; Cho WC
    Expert Opin Biol Ther; 2016 Oct; 16(10):1209-23. PubMed ID: 27426430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC).
    Yoneda K; Imanishi N; Ichiki Y; Tanaka F
    J UOEH; 2018; 40(2):173-189. PubMed ID: 29925736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated psoriasis: Epidemiology, pathogenesis, and management.
    Ceccarelli M; Venanzi Rullo E; Vaccaro M; Facciolà A; d'Aleo F; Paolucci IA; Cannavò SP; Cacopardo B; Pinzone MR; Pellicanò GF; Condorelli F; Nunnari G; Guarneri C
    Dermatol Ther; 2019 Mar; 32(2):e12806. PubMed ID: 30588732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost Effectiveness and Health Economics of Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer].
    Kogure Y
    Gan To Kagaku Ryoho; 2018 May; 45(5):781-784. PubMed ID: 30026436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer therapies in HIV cure research.
    Rasmussen TA; Anderson JL; Wightman F; Lewin SR
    Curr Opin HIV AIDS; 2017 Jan; 12(1):96-104. PubMed ID: 27607592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of Advanced or Postoperative Recurrent Non-small Lung Cancer Cases Treated with Nivolumab].
    Ichiki Y; Iwanami T; Kakizoe K; Hamatsu T; Suehiro T; Yoneda K; Tanaka F; Sugimachi K
    J UOEH; 2017; 39(4):291-297. PubMed ID: 29249742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Changing Face of HIV-Associated Malignancies: Advances, Opportunities, and Future Directions.
    Lurain K; Yarchoan R; Ramaswami R
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():36-40. PubMed ID: 31099683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer.
    Watanabe H; Kubo T; Ninomiya K; Kudo K; Minami D; Murakami E; Ochi N; Ninomiya T; Harada D; Yasugi M; Ichihara E; Ohashi K; Fujiwara K; Hotta K; Tabata M; Maeda Y; Kiura K
    Jpn J Clin Oncol; 2019 Aug; 49(8):762-765. PubMed ID: 31090906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoprogression in lung cancer patients treated with immunotherapy.
    Chen MY; Zeng YC
    Crit Rev Oncol Hematol; 2022 Jan; 169():103531. PubMed ID: 34800651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.